申请人:BANYU PHARMACEUTICAL CO., LTD.
公开号:EP1342717A1
公开(公告)日:2003-09-10
This invention relates to the compounds represented by a general formula [I]:
[in which A1 and A2 represent optionally fluorine-substituted methine or the like; B represents halogen, cyano, lower alkyl or the like; D represents optionally substituted heterocyclic group or the like; and G represents C3-C20 aliphatic group such as alicyclic group]. These compounds inhibit nociceptin activities due to their high affinity to nociceptin receptor, and are useful as analgesic, antiobestic, corebral function improver, drugs for treatment of alzheimer's disease and dementia, remedies for schizophrenia and neurodegenerative diseases, antidepressant, remedies for diabetes insipidus, polyuria, hypotension and so on.
本发明涉及通式[I]所代表的化合物:
[其中 A1 和 A2 代表任选氟取代的甲基或类似物;B 代表卤素、氰基、低级烷基或类似物;D 代表任选取代的杂环基团或类似物;G 代表 C3-C20 脂肪族基团,例如脂环族基团]。这些化合物由于与痛觉素受体的高亲和力而抑制痛觉素的活性,可用作镇痛剂、抗镇静剂、改善大脑核心功能的药物、治疗老年痴呆症和痴呆症的药物、治疗精神分裂症和神经退行性疾病的药物、抗抑郁剂、治疗糖尿病、多尿、低血压等。